Core Viewpoint - Jichuan Pharmaceutical (600566) announced that its pediatric cough syrup, a modified new drug based on the existing pediatric cough granules, is set to be approved for market launch in November 2023, with availability on online platforms like JD.com and steady progress in hospital entry work [1] Group 1 - The pediatric cough syrup demonstrates non-inferior efficacy compared to the already marketed pediatric cough granules for treating pediatric wind-heat cold with stagnation syndrome [1] - The syrup formulation offers convenience in administration, better taste, and improved drug absorption, providing a new option for pediatric patients [1] - The product aims to better meet the differentiated medication needs of children [1]